Avanza Fonder
VRTX icon

Avanza Fonder’s Vertex Pharmaceuticals VRTX Stock Holding History

Avanza Fonder’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.3M Buy
31,239
+3,041
+11% +$1.56M 0.31% 59
2026
Q2 		$14M Buy
28,198
+551
+2% +$244K 0.3% 60
2026
Q1 		$12.3M Buy
27,647
+62
+0.2% +$28.9K 0.34% 58
2025
Q4 		$12.5M Buy
27,585
+532
+2% +$229K 0.32% 59
2025
Q3 		$10.6M Buy
27,053
+1,628
+6% +$680K 0.27% 64
2025
Q2 		$11.3M Buy
25,425
+1,405
+6% +$647K 0.34% 52
2025
Q1 		$11.6M Sell
24,020
-4,138
-15% -$1.93M 0.38% 47
2024
Q4 		$11.3M Buy
+28,158
New +$13.1M 0.34% 53

Other funds holding VRTX

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Avanza Fonder's VRTX Position: Q3 2026 in Review

Avanza Fonder increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q3 2026, buying an estimated $1.56M and bringing the position to 31,239 shares worth $16.3M. The position accounts for 0.31% of the portfolio, ranked #59.

Avanza Fonder first reported a position in VRTX in Q4 2024 and has held it in 8 quarters since. 1,267 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Avanza Fonder held 31,239 shares of Vertex Pharmaceuticals worth $16.3M as of Q3 2026.
  • Avanza Fonder bought 3,041 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.56M.
  • Vertex Pharmaceuticals made up 0.31% of Avanza Fonder's portfolio in Q3 2026, its #59 holding.
  • Avanza Fonder first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 1,267 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Avanza Fonder's 13F filing for Q3 2026, filed 13 Oct 2026.